← Leaderboards
James T Handa
Johns Hopkins University
$18,072,691
Attributed
$21,131,723
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,131,723 · 8
By mechanism
R01$18,708,056 · 6
R42$1,399,056 · 1
K12$1,024,611 · 1
Top collaborators
- Andrew Joseph Kocab5 shared
- Debasish Sinha5 shared
- Harry Alan Quigley3 shared
- Shusheng Wang2 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Peter A Campochiaro$21,020,539
- Pierre Coulombe$26,047,228
- David Alan Kass$45,555,857
- Laura Ensign$10,004,174
- Malia Michelle Edwards$4,407,329
Others in their field
Top investigators on “Structure Of Retinal Pigment Epithelium”
- Krzysztof Palczewski · University Of California-Irvine$30,404,413
- Keri Hammel · The Emmes Company, Llc$26,462,048
- Supriya Menezes · The Emmes Company, Llc$25,277,032
- Ehud Isacoff · University Of California Berkeley$23,946,000
- Janet R. Sparrow · Columbia University Health Sciences$18,756,304
- David M Gamm · University Of Wisconsin-Madison$14,278,447
Research focus
Structure Of Retinal Pigment EpitheliumAge Related Macular DegenerationPhenotypeChronicCellsAgingLinkPreventAntioxidantsResponseOxidative StressBlindnessSignal TransductionGeneticFunctional DisorderElderlyRetinaInflammationEffective TherapyCigarette SmokeApoptosisImpairmentMediatingPathologic
Grant awards (44)
Does age/stress-induced mitochondrial dysfunction induce variations in RPE phenotype in AMD?$651,702
R01 · FY2025 · EY
The role of epigenetics in RPE heterogeneity with early AMD$374,865
R01 · FY2025 · EY · contact PI
Does age/stress-induced mitochondrial dysfunction induce variations in RPE phenotype in AMD?$610,403
R01 · FY2024 · EY
Targeting lysosome/RPE heterogeneity in AMD pathobiology as a novel therapy$584,501
R01 · FY2024 · EY
The role of epigenetics in RPE heterogeneity with early AMD$450,843
R01 · FY2024 · EY · contact PI
The Wilmer Institute Mentored Clinician Scientist Scholar Program$341,537
K12 · FY2024 · EY · contact PI
Targeting lysosome/RPE heterogeneity in AMD pathobiology as a novel therapy$17,789
R01 · FY2024 · EY
Targeting lysosome/RPE heterogeneity in AMD pathobiology as a novel therapy$607,796
R01 · FY2023 · EY
The role of epigenetics in RPE heterogeneity with early AMD$457,393
R01 · FY2023 · EY · contact PI
The Wilmer Institute Mentored Clinician Scientist Scholar Program$341,537
K12 · FY2023 · EY · contact PI
Targeting lysosome/RPE heterogeneity in AMD pathobiology as a novel therapy$594,408
R01 · FY2022 · EY
The role of epigenetics in RPE heterogeneity with early AMD$467,840
R01 · FY2022 · EY · contact PI
The Wilmer Institute Mentored Clinician Scientist Scholar Program$341,537
K12 · FY2022 · EY
Therapeutic inhibition of Fas-mediated retinal cell death and inflammation in dry AMD$120,000
R42 · FY2022 · EY
Targeting lysosome/RPE heterogeneity in AMD pathobiology as a novel therapy$627,798
R01 · FY2021 · EY
Oxidative stress and innate immunity impair the visual cycle$537,024
R01 · FY2021 · EY · contact PI
Therapeutic inhibition of Fas-mediated retinal cell death and inflammation in dry AMD$352,130
R42 · FY2021 · EY
Therapeutic inhibition of Fas-mediated retinal cell death and inflammation in dry AMD$8,541
R42 · FY2021 · EY
Therapeutic inhibition of Fas-mediated retinal cell death and inflammation in dry AMD$618,183
R42 · FY2020 · EY
Oxidative stress and innate immunity impair the visual cycle$558,253
R01 · FY2020 · EY · contact PI
Oxidative stress and innate immunity impair the visual cycle$558,253
R01 · FY2019 · EY · contact PI
Oxidative stress and innate immunity impair the visual cycle$557,969
R01 · FY2018 · EY · contact PI
Therapeutic inhibition of Fas-mediated retinal cell death and inflammation in dry AMD$300,202
R42 · FY2018 · EY
Oxidative stress and innate immunity impair the visual cycle$527,646
R01 · FY2017 · EY · contact PI
Nrf2 signaling and oxidative stress in age-related macular degeneration$576,492
R01 · FY2016 · EY · contact PI
Nrf2 signaling and oxidative stress in age-related macular degeneration$564,961
R01 · FY2015 · EY · contact PI
AGE-induced Phenotype of the Retinal Pigment Epithelium$542,575
R01 · FY2015 · EY · contact PI
Nrf2 signaling and oxidative stress in age-related macular degeneration$576,492
R01 · FY2014 · EY · contact PI
AGE-induced Phenotype of the Retinal Pigment Epithelium$542,577
R01 · FY2014 · EY · contact PI
Nrf2 signaling and oxidative stress in Age-related macular degeneration$564,655
R01 · FY2013 · EY · contact PI
AGE-induced Phenotype of the Retinal Pigment Epithelium$525,967
R01 · FY2013 · EY · contact PI
AGE-induced Phenotype of the Retinal Pigment Epithelium$617,650
R01 · FY2012 · EY · contact PI
Nrf2 signaling and oxidative stress in Age-related macular degeneration$596,835
R01 · FY2012 · EY · contact PI
Nrf2 signaling and oxidative stress in Age-related macular degeneration$594,380
R01 · FY2011 · EY · contact PI
AGE-induced Phenotype of the Retinal Pigment Epithelium$545,018
R01 · FY2011 · EY · contact PI
Nrf2 signaling and oxidative stress in Age-related macular degeneration$627,293
R01 · FY2010 · EY · contact PI
AGE-induced Phenotype of the Retinal Pigment Epithelium$545,274
R01 · FY2010 · EY · contact PI
AGE-induced Phenotype of the Retinal Pigment Epithelium$538,286
R01 · FY2009 · EY · contact PI
AGE-induced Phenotype of the Retinal Pigment Epithelium$528,928
R01 · FY2008 · EY · contact PI
AGE-induced Phenotype of the Retinal Pigment Epithelium$408,750
R01 · FY2005 · EY
AGE-induced Phenotype of the Retinal Pigment Epithelium$408,750
R01 · FY2004 · EY
AGE-induced Phenotype of the Retinal Pigment Epithelium$408,750
R01 · FY2003 · EY
AGE-induced Phenotype of the Retinal Pigment Epithelium$406,905
R01 · FY2002 · EY
AGE-induced Phenotype of the Retinal Pigment Epithelium$403,035
R01 · FY2001 · EY